DuPont Reports Third Quarter 2012 Results

                  DuPont Reports Third Quarter 2012 Results

Launches Targeted Restructuring Plan to Accelerate Productivity,
Competitiveness and Growth

PR Newswire

WILMINGTON, Del., Oct. 23, 2012

WILMINGTON, Del., Oct. 23, 2012 /PRNewswire/ --

  oThird-quarter 2012 earnings from continuing operations, excluding
    significant items, were $.32 per share versus $.60 per share in the prior
    year (see Schedule B.) Current quarter reported earnings (losses) from
    continuing operations were $(.05) per share versus $.39 per share in the
    prior year.

  oTotal company third-quarter 2012 earnings, excluding significant items,
    were $.44 per share versus $.69 per share in the prior year. Total
    company reported earnings were $.01 per share versus $.48 per share in the
    prior year (see Schedule D.)

  oThe company's Performance Coatings business, now pending divestiture, has
    been reclassified and reported as discontinued operations for all periods
    presented.

  oThird-quarter sales from continuing operations were $7.4 billion or 9
    percent below last year, primarily reflecting volume declines in
    Electronics & Communications and Performance Chemicals, particularly in
    Asia Pacific. Company sales reflect 5 percent lower volume, 4 percent
    negative currency impact and a 1 percent net reduction from portfolio
    changes, which were partly offset by 1 percent higher local prices. 

  oAgriculture sales increased 4 percent on higher volume and prices,
    inclusive of a 10 percent currency headwind. Performance Materials and
    Nutrition & Health delivered strong earnings growth in the quarter.

  oThe company has commenced a restructuring plan to increase productivity,
    enhance competitiveness and accelerate growth. The plan will deliver
    pre-tax cost savings of about $450 million ($300 million in 2013) by
    eliminating corporate costs supporting Performance Coatings and taking 
    additional cost-cutting actions to improve competitiveness. The
    restructuring plan includes eliminating about 1,500 positions globally in
    the next 12-18 months. In addition, the company remains on track to
    achieve its full-year 2012 productivity targets for both fixed costs and
    working capital.

  oDuPont expects its full-year 2012 earnings from continuing operations,
    excluding significant items, to be in a range of $3.25 to $3.30 per share.
    Prior-year earnings were $3.55 per share on a comparable basis.

"Today, we are taking additional actions to improve competitiveness and
accelerate market-driven innovation and growth by fine-tuning the
organization, eliminating costs and expanding beyond our everyday focus on
productivity," said DuPont Chair and CEO Ellen Kullman. "We continue to
execute well in many parts of the company, and certain segments are
outperforming despite market volatility. Weaker than expected demand in
titanium dioxide and photovoltaic markets contributed to the decline from last
year's record third-quarter earnings. We are addressing these challenges now
to position ourselves for improved performance."

Results from Continuing Operations

Third-quarter 2012 consolidated net sales of $7.4 billion were 9 percent lower
than the prior year reflecting 5 percent lower volume, 4 percent negative
currency impact and a 1 percent net reduction from portfolio changes, partly
offset by 1 percent higher local prices. The table below shows regional sales
and variances versus the third quarter 2011.

                         Three Months
                         Ended              Percentage Change Due to:
                         September 30,
                         2012
(Dollars in billions)    $          %       Local  Currency  Volume  Portfolio
                                    Change  Price  Effect            /Other
U.S. & Canada            $   2.5  (4)     2      -         (2)     (4)
EMEA*                    1.6        (15)    1      (11)      (6)     1
Asia Pacific             1.9        (15)    (5)    (1)       (10)    1
Latin America            1.4        (1)     5      (8)       2       -
Total Consolidated       $   7.4  (9)     1      (4)       (5)     (1)
Sales
* Europe, Middle East & Africa

Third-quarter 2012 income from continuing operations was a loss of $40 million
versus income of $376 million in 2011. Excluding significant items, income
from continuing operations was $302 million down $277 million, or 48 percent,
from $579 million in the third quarter 2011.

Earnings Per Share

The table below shows year-over-year earnings per share (EPS) variances for
continuing operations, excluding significant items, for the third quarter.

EPS ANALYSIS-Continuing Operations
                                                                      3Q
EPS 2011                                                              $.39
Less: Significant items (schedule B)                       (.21)
EPS 2011 – Excluding significant items                                $.60
                                                                     

Local prices                                                          .05
Variable cost*                                                        .17
Volume                                                                (.15)
Fixed cost*                                                           (.08)
Currency                                                              (.13)
Exchange losses                                                       (.02)
 Income tax                                                        (.05)
 Pharmaceuticals income                                            (.05)
 Other                                               (.02)

EPS 2012 – Excluding significant items                              $.32
Significant items - (schedule B)                                     (.37)
EPS 2012                                                              $(.05)
*Excluding volume and currency impacts

Business Segment Performance

The table below shows third quarter 2012 segment sales and related variances
versus the prior year.

SEGMENT SALES*            Three Months Ended  Percentage Change
(Dollars in billions)     September 30, 2012  Due to:
                          $         % Change  USD Price  Volume  Portfolio and
                                                                 Other
Agriculture               $       4         (3)        7       0
                          1.4
Electronics &             0.6       (28)      (8)        (20)    0
Communications
Industrial Biosciences    0.3       0         (7)        7       0
Nutrition & Health        0.9       4         0          4       0
Performance Chemicals     1.7       (19)      (1)        (18)    0
Performance Materials     1.6       (8)       (7)        2       (3)
Safety & Protection       0.9       (7)       (4)        (3)     0

Segment pre-tax operating income (PTOI) from continuing operations for third
quarter 2012 was $356 million compared to third quarter 2011 PTOI of $778
million. Excluding significant items, PTOI was $816 million, down 24 percent
from $1,071 million in the prior year, as shown in the table below.

SEGMENT PTOI excluding Significant Items*              Change versus 2011
(Dollars in millions)          3Q 2012     3Q 2011     $             %
Agriculture                    $   (85)  $   (69)  $   (16)    -23%
Electronics & Communications   40          99          (59)          -60%
Industrial Biosciences         42          34          8             24%
Nutrition & Health             87          55          32            58%
Performance Chemicals          372         593         (221)         -37%
Performance Materials          306         231         75            32%
Safety & Protection            103         118         (15)          -13%
Other                          (59)        (60)        1             2%
                               $   806   $ 1,001    $  (195)     -19%
Pharmaceuticals                10          70          (60)          -86%
Total Segment PTOI             $   816   $ 1,071    $  (255)     -24%

* See schedules B and C for listing of significant items and their impact by
segment.

The following is a summary of business results for each of the company's
reportable segments, comparing third quarter 2012 with third quarter 2011, for
sales and PTOI (loss), excluding significant items. References to price are
on a U.S. dollar basis, including the impact of currency.

Agriculture – Sales of $1.4 billion were up 4 percent on 7 percent higher
volume partially offset by 3 percent lower prices inclusive of a 10 percent
currency headwind. For Pioneer seed, volume growth reflects a strong start to
the Southern Hemisphere planting season. Higher local prices for both corn
and soybeans were partially offset by the impact of unfavorable currency.
Crop Protection sales growth was underpinned by strong demand for insect
control products and fungicides; while higher local prices across all market
segments were more than offset by unfavorable currency. PTOI seasonal loss
was ($85) million versus ($69) million in the prior year as strong sales were
more than offset by unfavorable currency, higher input costs in seeds and
higher investments in commercial and R&D activities to support growth.

Electronics & Communications – Sales of $607 million were down 28 percent on
20 percent lower volume and 8 percent lower prices, primarily pass-through of
lower metals prices. Volume declined in photovoltaic materials, partially
offset by continued strong demand for materials in smart phones and tablets.
PTOI of $40 million declined $59 million from lower volume.

Industrial Biosciences – Sales of $292 million were flat compared to prior
year as higher volume was offset by lower prices, primarily related to
unfavorable currency. Volume growth reflects strong biomaterial sales into
carpeting, as well as continued growth in animal nutrition and food enzymes.
PTOI of $42 million was up $8 million on higher volume and the realization of
cost synergies related to the integration of the Danisco enzyme business.

Nutrition & Health –  Sales of $876 million were up 4 percent on higher
volume, reflecting strong demand for specialty food ingredients and Solae soy
specialties. Higher local prices were offset by unfavorable currency. PTOI
of $87 million was up $32 million on higher local selling prices, higher
volume and the realization of cost synergies related to the integration of the
Danisco specialty food ingredients business.

Performance Chemicals – Sales of $1.7 billion were down 19 percent, with 18
percent lower volume and 1 percent lower prices against a quarter with record
titanium dioxide volume. Sales declined on lower demand for titanium dioxide
and fluoropolymers. Volumes were pressured by softness in Europe and Asia
Pacific primarily due to lower infrastructure spend and weak construction
markets. PTOI of $372 million decreased $221 million on lower volume.

Performance Materials – Sales of $1.6 billion were down 8 percent, with 7
percent lower prices and a 3 percent reduction from a portfolio change,
partially offset by 2 percent higher volume. Lower prices reflect unfavorable
currency and mix. Stable packaging markets and continued strong demand in
automotive were partially offset by softness in the industrial and electronics
markets. PTOI of $306 million increased $75 million due to lower feedstock
costs and higher volume, partially offset by unfavorable currency.

Safety & Protection – Sales of $934 million were down 7 percent, with 4
percent lower prices, primarily due to unfavorable currency, and 3 percent
lower volume. Volume declined due to stalled infrastructure projects in
China, weaker industrial conditions in Europe and lower US public sector
demand. Trends in US housing are encouraging. PTOI of $103 million decreased
$15 million on weaker mix and unfavorable currency.

Additional information is available on the DuPont Investor Center website at
www.investors.dupont.com.

Outlook

DuPont expects its full-year 2012 earnings from continuing operations,
excluding significant items, to be in a range of $3.25 to $3.30 per share.
Prior-year earnings were $3.55 per share on a comparable basis.

Update on Performance Coatings Sale

On August 30, 2012, DuPont announced that it signed a definitive agreement to
sell its Performance Coatings business for $4.9 billion in cash and the
assumption of $250 million of unfunded pension liabilities. DuPont estimates
that the after-tax cash proceeds will be about $4 billion. Beginning with the
third quarter results, the Performance Coatings segment has been classified as
discontinued operations and is excluded from the company's continuing
operations results, on a retroactive basis. Current quarter earnings from
discontinued operations were $.06 per share, which included a $.06 charge
related to additional deferred tax liabilities. Prior year earnings were $.09
per share. Excluding the $.06 charge related to additional deferred tax
liabilities, the company expects earnings from discontinued operations to be
about $.41 per share for full year 2012. The sale is expected to close in the
first quarter of 2013.

Use of Non-GAAP Measures

Management believes that certain non-GAAP measurements are meaningful to
investors because they provide insight with respect to ongoing operating
results of the company. Such measurements are not recognized in accordance
with generally accepted accounting principles (GAAP) and should not be viewed
as an alternative to GAAP measures of performance. Reconciliations of
non-GAAP measures to GAAP are provided in schedules C and D.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the
global marketplace in the form of innovative products, materials, and services
since 1802. The company believes that by collaborating with customers,
governments, NGOs, and thought leaders we can help find solutions to such
global challenges as providing enough healthy food for people everywhere,
decreasing dependence on fossil fuels, and protecting life and the
environment.For additional information about DuPont and its commitment to
inclusive innovation, please visit http://www.dupont.com.

Forward-Looking Statements: This news release contains forward-looking
statements which may be identified by their use of words like "plans,"
"expects," "will," "anticipates," "believes," "intends," "estimates" or other
words of similar meaning. All statements that address expectations or
projections about the future, including statements about the company's growth
strategy, product development, regulatory approval, market position,
anticipated benefits of acquisitions, outcome of contingencies, such as
litigation and environmental matters, expenditures and financial results, are
forward-looking statements. Forward-looking statements are not guarantees of
future performance and are based on certain assumptions and expectations of
future events which may not be realized. Forward-looking statements also
involve risks and uncertainties, many of which are beyond the company's
control. Some of the important factors that could cause the company's actual
results to differ materially from those projected in any such forward-looking
statements are: fluctuations in energy and raw material prices; failure to
develop and market new products and optimally manage product life cycles;
significant litigation and environmental matters; failure to appropriately
manage process safety and product stewardship issues; changes in laws and
regulations or political conditions; global economic and capital markets
conditions, such as inflation, interest and currency exchange rates; business
or supply disruptions; security threats, such as acts of sabotage, terrorism
or war, weather events and natural disasters; inability to protect and enforce
the company's intellectual property rights; and integration of acquired
businesses and completion of divestitures of underperforming or non-strategic
assets or businesses. The company undertakes no duty to update any
forward-looking statements as a result of future developments or new
information.

E. I. du Pont de Nemours and Company
Consolidated Income Statements
(Dollars in millions, except per share amounts)
SCHEDULE A
                            Three Months Ended        Nine Months Ended
                            September 30,             September 30,
                            2012         2011         2012         2011
Net sales                   $       $       $        $    
                            7,390       8,138        27,487       26,338
Other (loss) income,        (54)         165          251          404
net^(a)
Total                       7,336        8,303        27,738       26,742
Cost of goods sold and
other operating charges     5,722        6,345        19,621       18,947
^(a)
Selling, general and        772          809          2,725        2,567
administrative expenses
Research and
development expense         506          546          1,520        1,383
^(a)
Interest expense           116          116          347          331
Employee separation /
asset related charges,      394          36           394          36
net ^(a)
Total                       7,510        7,852        24,607       23,264
(Loss) income from
continuing operations       (174)        451          3,131        3,478
before income taxes
(Benefit from)
provision for income        (134)        75           657          616
taxes on continuing
operations
(Loss) income from
continuing operations       (40)         376          2,474        2,862
after income taxes
Net income from
discontinued operations     53           84           227          271
after taxes
Net income                 13           460          2,701        3,133
Less: Net income
attributable to             3            8            24           32
noncontrolling
interests
Net income attributable     $       $       $       $     
to DuPont                   10      452       2,677        3,101
Basic (loss) earnings
per share of common
stock:
Basic (loss) earnings
per share of common         $       $       $       $     
stock from continuing       (0.05)       0.39        2.62        3.04
operations
Basic earnings per
share of common stock       0.06         0.09         0.24         0.29
from discontinued
operations
Basic earnings per          $       $       $       $     
share of common stock        0.01       0.48        2.86        3.33
Diluted (loss) earnings
per share of common
stock:
Diluted (loss) earnings
per share of common         $       $       $       $     
stock from continuing       (0.05)       0.39        2.59        2.99
operations
Diluted earnings per
share of common stock       0.06         0.09         0.24         0.29
from discontinued
operations
Diluted earnings per        $       $       $       $     
share of common stock        0.01       0.48        2.83        3.28
Dividends per share of      $       $       $       $     
common stock              0.43       0.41        1.27        1.23
Average number of shares
outstanding used in
earnings / (loss) per
share (EPS) calculation:
 Basic                     931,737,000  932,356,000  933,227,000  929,369,000
 Diluted                   940,526,000  943,485,000  942,524,000  942,812,000
(a) See Schedule B for
detail of significant
items.



E. I. du Pont de Nemours and Company
Condensed Consolidated Balance Sheets
(Dollars in millions, except per share amounts)
SCHEDULE A (continued)
                                             September 30,    December 31,
                                             2012             2011
Assets
Current assets
Cash and cash equivalents                    $     3,418  $     3,586
Marketable securities                        105              433
Accounts and notes receivable, net          7,879            6,022
Inventories                                 6,752            7,195
Prepaid expenses                             135              151
Deferred income taxes                       971              671
Assets held for sale                         3,157            -
Total current assets                         22,417           18,058
Property, plant and equipment, net of
accumulated depreciation                     12,528           13,412
 (September 30, 2012 - $18,892; December
31, 2011 - $19,349)
Goodwill                                     4,579            5,413
Other intangible assets                     5,145            5,413
Investment in affiliates                     1,098            1,117
Deferred income taxes                       3,825            4,067
Other assets                                 1,015            1,012
Total                                        $    50,607   $    48,492
Liabilities and Equity
Current liabilities
Accounts payable                             $     4,154  $     4,816
Short-term borrowings and capital lease      4,564            817
obligations
Income taxes                                644              255
Other accrued liabilities                    3,831            5,297
Liabilities related to assets held for sale  1,010            -
Total current liabilities                    14,203           11,185
Long-term borrowings and capital lease       10,502           11,736
obligations
Other liabilities                            14,136           15,508
Deferred income taxes                        1,055            1,001
Total liabilities                            39,896           39,430
Commitments and contingent liabilities
Stockholders' equity
Preferred stock                              237              237
Common stock, $0.30 par value;
1,800,000,000 shares authorized;
 Issued at September 30, 2012 -            306              304
1,019,411,000; December 31, 2011 -
1,013,164,000
Additional paid-in capital                   10,594           10,107
Reinvested earnings                          14,581           13,422
Accumulated other comprehensive loss        (8,385)          (8,750)
Common stock held in treasury, at cost
(87,041,000 shares                           (6,727)          (6,727)
 at September 30, 2012 and December 31,
2011)
Total DuPont stockholders' equity            10,606           8,593
Noncontrolling interests                     105              469
Total equity                                 10,711           9,062
Total                                        $    50,607   $    48,492



E. I. du Pont de Nemours and Company
Condensed Consolidated Statement of Cash Flows
(Dollars in millions)
SCHEDULE A (continued)
                                              Nine Months Ended
                                              September 30,
Total Company                                 2012             2011
Cash provided by (used for) operating         $     (426)  $      431
activities
Investing activities
Purchases of property, plant and equipment    (1,139)          (1,211)
Investments in affiliates                     (31)             (35)
Payments for businesses (net of cash          (18)             (6,459)
acquired)
Net (increase) decrease in short-term         336              2,365
financial instruments
Other investing activities - net              185              (236)
Cash provided by (used for) investing         (667)            (5,576)
activities
Financing activities
Dividends paid to stockholders                (1,191)          (1,152)
Net increase (decrease) in borrowings         2,524            4,503
Repurchase of common stock                    (400)            (672)
Proceeds from exercise of stock options       520              833
Payments for noncontrolling interest          (447)            -
Other financing activities - net              38               52
Cash provided by (used for) financing         1,044            3,564
activities
Effect of exchange rate changes on cash       (23)             68
Cash classified as held for sale              (96)             -
Increase (decrease) in cash and cash          (168)            (1,513)
equivalents
Cash and cash equivalents at beginning of     3,586            4,263
period
Cash and cash equivalents at end of period    $    3,418   $    2,750



E. I. du Pont de Nemours and Company
Schedule of Significant Items from Continuing Operations
(Dollars in millions, except per share amounts)
SCHEDULE B
SIGNIFICANT ITEMS FROM
CONTINUING OPERATIONS
                      Pre-tax             After-tax           ($ Per Share)
                      2012      2011      2012      2011      2012     2011
1st Quarter
Customer claims       $        $      $        $      $       $   
charge ^(a)           (50)      -       (32)      -       (0.04)    -
1st Quarter - Total   $        $      $        $      $       $   
                      (50)      -       (32)      -       (0.04)    -
2nd Quarter
Customer claims       $ (265)  $      $ (169)  $      $       $   
charge ^(a)                     -                   -         (0.18)   -
Litigation settlement (137)     -         (123)     -         (0.13)   -
^(b)
Gain on the sale of
equity
  method investment   122       -         77        -         0.08     -
  ^(c)
Transition costs
related to the
  acquisition of      -         (103)     -         (81)      -        (0.08)
  Danisco^(d)
2nd Quarter - Total   $ (280)  $ (103)  $ (215)  $        $       $ 
                                                    (81)     (0.23)  (0.08)
3rd Quarter
Customer claims       $ (125)  $        $        $        $       $ 
charge ^(a)                     (75)     (80)     (48)     (0.09)  (0.05)
Restructuring charge  (152)     -         (105)     -         (0.11)   -
^(e)
Asset impairment      (242)     -         (157)     -         (0.17)   -
charge ^(f)
Transition costs and
restructuring charge
  related to the
  acquisition of      -         (171)     -         (122)     -        (0.13)
  Danisco ^(g)
Charge related to
milestone payment
  for licensing       -         (50)      -         (33)      -        (0.03)
  agreement ^(h)
3rd Quarter - Total   $ (519)  $ (296)  $ (342)  $ (203)  $       $ 
                                                              (0.37)  (0.21)
Year-to-date -        $ (849)  $ (399)  $ (589)  $ (284)  $       $ 
Total^(i)                                                     (0.63)  (0.30)



E. I. du Pont de Nemours and Company
Schedule of Significant Items from Continuing Operations
(Dollars in millions, except per share amounts)
SCHEDULE B (continued)
SIGNIFICANT ITEMS FROM CONTINUING OPERATIONS
    Third quarter 2012, second quarter 2012, first quarter 2012 and third
    quarter 2011 included charges of $125, $265, $50 and $75, respectively,
    recorded in Cost of goods sold and other operating charges associated with
    the company's process to fairly resolve claims related to the use of
    Imprelis® herbicide, bringing the total charges to $615 at September 30,
(a) 2012. The company will continue to evaluate reported claim damage as
    additional information becomes available. It is reasonably possible that
    additional charges could result from this evaluation. While there is a
    high degree of uncertainty, total charges could range as high as $700. The
    company has submitted, and will continue to submit, requests for payment
    to its insurance carriers for costs associated with this matter in excess
    of $100. This matter relates to the Agriculture segment.
    Second quarter 2012 included a charge of $137 recorded in Cost of goods
(b) sold and other operating charges primarily related to the company's
    settlement of litigation with Invista. This matter relates to Other.
    Second quarter 2012 included a pre-tax gain of $122 recorded in Other
(c) income, net associated with the sale of an equity method investment in the
    Electronics & Communications segment.
    Second quarter 2011 included charges related to the Danisco acquisition of
    $(103) recorded in Cost of goods sold and other operating charges. These
    charges included $(60) of transaction costs and a $(43) charge related to
(d) the fair value step-up of inventories that were acquired from Danisco and
    sold in the second quarter 2011. Pre-tax charges by segment were:
    Industrial Biosciences - $(17), Nutrition & Health - $(33), and Corporate
    expenses - $(53).
    Third quarter 2012 included a $152 restructuring charge recorded in
    Employee separation/asset related charges, net consisting of $133 of
    severance and related benefit costs and $19 of asset related charges as a
    result of the company's plan to eliminate corporate costs previously
(e) allocated to Performance Coatings and cost-cutting actions to improve
    competitiveness. Pre-tax charges by segment were: Agriculture - $(3),
    Nutrition & Health - $(13), Electronics & Communications - $(7),
    Performance Chemicals - $(3), Performance Materials - $(9), Safety &
    Protection - $(55), Industrial Biosciences - $(3), and Corporate expenses
    - $(59).
    Third quarter 2012 included a $242 impairment charge recorded in Employee
    separation/asset related charges, net related to asset groupings within
    the Electronics & Communications and Performance Materials segments. The
(f) charge of $150 within Electronics & Communications was a result of
    conditions within the thin film photovoltaic market. The charge of $92
    within Performance Materials was the result of deteriorating conditions in
    an industrial polymer market.
    Third quarter 2011 included charges related to the Danisco acquisition of
    $(171). These charges included $(135) recorded in Cost of goods sold and
    other operating charges for $(3) of transaction costs and a $(132) charge
    related to the fair value step-up of inventories that were acquired from
(g) Danisco and sold in the third quarter 2011. These charges also included a
    $(36) restructuring charge recorded in Employee separation / asset related
    charges, net related to severance and related benefit costs. Pre-tax
    charges by segment were: Industrial Biosciences - $(61), Nutrition &
    Health - $(89), Other - $(18), and Corporate expenses - $(3).
    Third quarter 2011 included a ($50) charge recorded in Research and
(h) development expense in connection with a milestone payment associated with
    a Pioneer licensing agreement.
(i) Earnings per share for the year may not equal the sum of quarterly
    earnings per share due to changes in average share calculations.
See Schedule C for detail by segment.



E. I. du Pont de Nemours and Company
Consolidated Segment Information
(Dollars in millions)
SCHEDULE C
                              Three Months Ended  Nine Months Ended
                              September 30,       September 30,
SEGMENT SALES ^(1)            2012      2011      2012       2011
Agriculture                   $ 1,423  $ 1,368  $  8,891  $  7,869
Electronics & Communications  607       841       2,079      2,543
Industrial Biosciences        292       293       880        416
Nutrition & Health            876       844       2,569      1,654
Performance Chemicals         1,732     2,142     5,600      5,934
Performance Materials         1,614     1,745     4,913      5,197
Safety & Protection           934       1,001     2,861      2,991
Other                         2         2         4          39
Total Segment sales           7,480     8,236     27,797     26,643
Elimination of transfers      (90)      (98)      (310)      (305)
Consolidated net sales        $ 7,390  $ 8,138  $ 27,487   $ 26,338
(1) Sales for the reporting segments include transfers.



E. I. du Pont de Nemours and Company
Consolidated Segment Information
(Dollars in millions)
SCHEDULE C (continued)
                                    Three Months Ended     Nine Months Ended
                                    September 30,          September 30,
PRE-TAX OPERATING INCOME/(LOSS)     2012        2011       2012       2011
(PTOI) FROM CONTINUING OPERATIONS
Agriculture                        $  (213)   $ (194)   $ 1,712   $ 1,743
Electronics & Communications        (117)       99         113        313
Industrial Biosciences              39          (27)       124        (34)
Nutrition & Health                  74          (34)       269        (4)
Performance Chemicals               369         593        1,419      1,490
Performance Materials               205         231        762        773
Safety & Protection                 48          118        275        406
Pharmaceuticals                    10          70         53         200
Other                               (59)        (78)       (325)      (179)
Total Segment PTOI                  356         778        4,402      4,708
Net exchange gains (losses) ^(1)    (130)       6          (161)      (132)
Corporate expenses & net interest   (400)       (333)      (1,110)    (1,098)
(Loss) income before income taxes   $  (174)   $  451   $ 3,131   $ 3,478
from continuing operations
                                    Three Months Ended     Nine Months Ended
                                    September 30,          September 30,
SIGNIFICANT ITEMS BY SEGMENT        2012        2011       2012       2011
(PRE-TAX) ^(2)
Agriculture                        $  (128)   $ (125)   $  (443)  $ (125)
Electronics & Communications        (157)       -          (35)       -
Industrial Biosciences              (3)         (61)       (3)        (78)
Nutrition & Health                  (13)        (89)       (13)       (122)
Performance Chemicals               (3)         -          (3)        -
Performance Materials               (101)       -          (101)      -
Safety & Protection                 (55)        -          (55)       -
Pharmaceuticals                    -           -          -          -
Other                               -           (18)       (137)      (18)
Total significant items by segment  $  (460)   $ (293)   $  (790)  $ (343)
                                    Three Months Ended     Nine Months Ended
                                    September 30,          September 30,
PTOI EXCLUDING SIGNIFICANT ITEMS  2012        2011       2012       2011
Agriculture                        $   (85)  $  (69)  $ 2,155   $ 1,868
Electronics & Communications        40          99         148        313
Industrial Biosciences              42          34         127        44
Nutrition & Health                  87          55         282        118
Performance Chemicals               372         593        1,422      1,490
Performance Materials               306         231        863        773
Safety & Protection                 103         118        330        406
Pharmaceuticals                    10          70         53         200
Other                               (59)        (60)       (188)      (161)
Total Segment PTOI excluding        $   816   $ 1,071    $ 5,192   $ 5,051
significant items
(1) See Schedule D for additional information on exchange gains and losses.
(2) See Schedule B for detail of significant items.



E. I. du Pont de Nemours and Company
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
SCHEDULE D
Summary of Earnings
Comparisons
                         Three Months Ended                Nine Months Ended
                         September 30,                    September 30,
                         2012         2011         %       2012         2011         %
                                                   Change                            Change
Segment PTOI             $       $       -54%    $       $       -6%
                           356        778              4,402        4,708
Significant items
(benefit) charge         460          293                  790          343
included in PTOI (per
Schedule C)
Segment PTOI excluding   $       $       -24%    $       $       3%
significant items          816      1,071               5,192        5,051
(Loss) income from       $       $               $       $     
continuing operations      (40)       376      -111%   2,474        2,862        -14%
after income taxes
Significant items
(benefit) charge
included in income from
continuing operations
after income taxes       342          203                  589          284
(per Schedule B)
Income from continuing
operations after income  $       $       -48%    $       $       -3%
taxes, excluding           302        579              3,063        3,146
significant items
EPS from                 $       $               $       $     
continuing               (0.05)       0.39      -113%    2.59        2.99       -13%
operations
Significant items
(benefit) charge         0.37         0.21                 0.63         0.30
included in EPS (per
Schedule B)
EPS from continuing      $       $               $       $     
operations, excluding     0.32       0.60      -47%     3.22        3.29       -2%
significant items
Net income from          $       $               $       $     
discontinued                53        84     -37%     227        271       -16%
operations after taxes
Significant item charge
related to taxes on
certain unremitted
Performance Coatings
earnings included in
net income from          62           -                    62           -
discontinued
operations after taxes
Net income from
discontinued operations  $       $       37%     $       $       7%
after taxes, excluding     115         84              289        271
significant item
EPS from                 $       $               $       $     
discontinued              0.06       0.09      -33%     0.24        0.29       -17%
operations
Significant item charge
related to taxes on
certain unremitted
Performance Coatings
earnings included in    0.06         -                    0.06         -
EPS
EPS from discontinued    $       $               $       $     
operations, excluding     0.12       0.09      33%      0.30        0.29       3%
significant item
EPS from total           $       $       -98%    $       $       -14%
company                   0.01       0.48               2.83        3.28
Significant items
(benefit) charge         0.43         0.21                 0.69         0.30
included in EPS
EPS from total           $       $               $       $     
company, excluding        0.44       0.69      -37%     3.52        3.58       -2%
significant items
Average number of
diluted shares           940,526,000  943,485,000  -0.3%   942,524,000  942,812,000  0.0%
outstanding
Reconciliation of
Earnings Per Share
(EPS) Outlook
                         Year Ended December 31,
                         2012         2011 Actual
                         Outlook
EPS from continuing      $3.25 -      $     
operations - excluding   $3.30      3.55
significant items
Sale of an equity        0.08         -
method investment
Danisco
acquisition              -            (0.22)
related costs
Customer claims          (0.30)       (0.12)
charges
Charges related to a     -            (0.03)
licensing agreement
Sale of a business       -            0.13
Restructuring            (0.11)       (0.01)
charge/adjustments
Litigation               (0.13)       -
settlement
Asset impairment         (0.17)       -
charge
4Q 2012 sale of          0.08         -
assets - estimate
Reported EPS from        $2.70 -      $     
continuing               $2.75      3.30
operations
EPS from discontinued    About      $     
operations - excluding   $0.41      0.38
significant items
Charge related to
taxes on certain         (0.06)       -
unremitted Performance
Coatings earnings
Reported EPS from        About      $     
discontinued             $0.35      0.38
operations



E. I. du Pont de Nemours and Company
Reconciliation of Non-GAAP Measures
(Dollars in millions)
SCHEDULE D
Reconciliations of Adjusted EBIT / EBITDA to Consolidated
Income Statements
                                    Three Months Ended       Nine Months Ended
                                    September 30,            September 30,
                                    2012            2011     2012      2011
(Loss) income from continuing       $           $     $      $   
operations before income taxes      (174)             451  3,131    3,478
Less: Net income attributable to    3               8        24        32
noncontrolling interests
Add: Interest expense             116             116      347       331
Adjusted EBIT from continuing       (61)            559      3,454     3,777
operations
Add: Depreciation and               393             367      1,237     1,058
amortization
Adjusted EBITDA from continuing     $          $     $      $   
operations                          332               926  4,691    4,835
Calculation of Free Cash Flow -
Total Company
                                    Nine Months Ended
                                    September 30,
                                    2012            2011
Cash provided by (used for)         $           $   
operating activities                (426)             431
Less: Purchases of property, plant  1,139           1,211
and equipment
Free cash flow                      $   (1,565)  $   
                                                     (780)



E. I. du Pont de Nemours and Company
Reconciliation of Non-GAAP Measures
(Dollars in millions)
SCHEDULE D (continued)
Exchange Gains/Losses
The company routinely uses forward exchange contracts to offset its net
exposures, by currency, related to the foreign currency denominated monetary
assets and liabilities of its operations. The objective of this program is to
maintain an approximately balanced position in foreign currencies in order to
minimize, on an after-tax basis, the effects of exchange rate changes. The net
pre-tax exchange gains and losses are recorded in Other income, net and the
related tax impact is recorded in Provision for (benefit from) income taxes on
the Consolidated Income Statements.

                                     Three Months Ended     Nine Months Ended
                                     September 30,          September 30,
                                     2012       2011        2012      2011
Subsidiary/Affiliate Monetary
Position Gain (Loss)
Pre-tax exchange gains (losses)      $       $  (216)  $       $   
(includes equity affiliates)         91                     (50)      70
Local tax benefits (expenses)        (6)        34          10        31
Net after-tax impact from            $                   $       $  
subsidiary exchange gains            85         $  (182)  (40)      101
(losses)
Hedging Program Gain (Loss)
Pre-tax exchange gains (losses)      $  (221)  $   222  $        $ 
                                                            (111)     (202)
Tax benefits (expenses)              77         (76)        38        70
Net after-tax impact from                                   $       $ 
hedging program exchange gains       $  (144)  $   146  (73)      (132)
(losses)
Total Exchange Gain (Loss)
Pre-tax exchange gains (losses)      $  (130)  $       $        $ 
                                                 6         (161)     (132)
Tax benefits (expenses)              71         (42)        48        101
Net after-tax exchange gains         $        $         $        $  
(losses) ^(1)                        (59)       (36)       (113)     (31)

As shown above, the "Total Exchange Gain (Loss)" is the sum of the
"Subsidiary/Affiliate Monetary Position Gain (Loss)" and the "Hedging Program
Gain (Loss)."
(1) The above Net after-tax exchange gains (losses) excludes gains (losses)
attributable to discontinued operations of $9 and $(11) for the three months
ended September 30, 2012 and 2011, respectively, and $(11) and $(12) for the
nine months ended September 30, 2012 and 2011, respectively.

Reconciliation of Base Income Tax Rate to Effective Income Tax Rate
Base income tax rate is defined as the effective income tax rate less the
effect of exchange gains/losses, as defined above, and significant items.
                                          Three Months Ended  Nine Months
                                          September 30,       Ended
                                                              September 30,
                                          2012       2011     2012       2011
(Loss) income from continuing operations  $  (174)  $      $ 3,131   $ 
before income taxes                                 451                3,478
Add: Significant items - (benefit)       519        296      849        399
charge^(1)
Less: Net exchange (losses) gains        (130)      6        (161)      (132)
Income from continuing operations before
income taxes, significant items and
exchange
gains/losses                              $   475  $      $ 4,141   $ 
                                                     741                4,009
(Benefit from) provision for income      $  (134)  $     $   657  $  
taxes on continuing operations                       75                 616
Add: Tax benefit (expenses) on           177        93       260        115
significant items
 Tax benefits (expenses) on      71         (42)     48         101
exchange gains/losses
Provision for income taxes on continuing
operations, excluding taxes on            $   114  $      $   965  $  
significant items                                    126                832
 and exchange gains/losses
Effective income tax rate                 77.0%      16.6%    21.0%      17.7%
Significant items effect                  (64.5%)    5.9%     2.0%       1.2%
Tax rate, from continuing operations,     12.5%      22.5%    23.0%      18.9%
before significant items
Exchange gains (losses) effect            11.5%      (5.5%)   0.3%       1.9%
Base income tax rate from continuing      24.0%      17.0%    23.3%      20.8%
operations
(1) See Schedule B for detail of significant items.



SOURCE DuPont

Website: http://www.dupont.com
Contact: Media, Michael Hanretta, +1-302-774-4005,
michael.j.hanretta@usa.dupont.com; or Investors, +1-302-774-4994
 
Press spacebar to pause and continue. Press esc to stop.